Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
Barrios
Carlos H
CH
PUCRS School of Medicine, Centro de Pesquisa em Oncologia, Jardim Botanico, Porto Alegre, RS, 90610-000, Brazil. chbe@via-rs.net
Liu
Mei-Ching
MC
Lee
Soo Chin
SC
Vanlemmens
Laurence
L
Ferrero
Jean-Marc
JM
Tabei
Toshio
T
Pivot
Xavier
X
Iwata
Hiroji
H
Aogi
Kenjiro
K
Lugo-Quintana
Roberto
R
Harbeck
Nadia
N
Brickman
Marla J
MJ
Zhang
Ke
K
Kern
Kenneth A
KA
Martin
Miguel
M